Elan Pharmaceuticals
Dublin · Founded 1986
About Elan Pharmaceuticals
Elan Pharmaceuticals, Inc. is an Ireland-based neuroscience-based technology company that engages in the research and development, and the sale of pharmaceutical products. The company was founded in 1986 and is based in South San Francisco, California. The company discovers, develops, manufactures and markets therapies for neurodegenerative diseases, autoimmune diseases, and severe pain. All the drugs, manufactured by the company are delivered to broad range of pharmaceutical companies, ranging from large global organizations to development stage companies. The company through its drug technologies has developed improved formulations of 35 products that were launched in over 100 countries. The company also markets its product, TYSABRI in United States, the European Union, Switzerland, Canada, and Australia. The company has its R&D, marketing and manufacturing located in Ireland and the U.S. Elan is headquartered in Dublin, Ireland. Elan Pharmaceuticals, Inc was acquired by Perrigo Co. (PRGO), a U.S. maker of over-the-counter medicines, in 2013 for $8.6 billion, gaining a low-tax base for international expansion.
Company Facts
- Founded: 1986
- Legal name: Elan Corporation plc
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 5,001 – 10,000
- Estimated revenue: $1M – $10M
- Website: elan.com
Social Profiles
Canonical: https://fsome.com/organization/elan-pharmaceuticals-8246789 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.